Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 3 , Pages 199-206 , Autumn 2009

Surgical Therapy for Complex Coronary Artery Disease

  • Andrew W. ElBardissi, MD, MPH

      Affiliations

    • Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Jorge M. Balaguer, MD

      Affiliations

    • Department of Cardiac Surgery, The Vanderbilit Heart Institute, Nashville, Tennessee
    • ,
  • John G. Byrne, MD

      Affiliations

    • Department of Cardiac Surgery, The Vanderbilit Heart Institute, Nashville, Tennessee
    • ,
  • Sary A. Aranki, MD

      Affiliations

    • Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationAddress reprint requests to Sary A. Aranki, MD, Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115

References 

  1. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, et al. Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: A systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2006;47:1576–1583
  2. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27:2667–2674
  3. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomised controlled trial. Lancet. 2002;360:965–970
  4. Goy JJ, Eeckhout E, Burnand B, et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet. 1994;343:1449–1453
  5. Goy JJ, Eeckhout E, Moret C, et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting (A prospective trial). Circulation. 1999;99:3255–3259
  6. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217–225
  7. King SB, Barnhart HX, Kosinski AS, et al. Angioplasty or surgery for multivessel coronary artery disease: Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes (Emory angioplasty versus Surgery Trial Investigators). Am J Cardiol. 1997;79:1453–1459
  8. Coronary angioplasty versus medical therapy for angina. The second randomised intervention treatment of angina (rita-2) trial (Rita-2 trial participants). Lancet. 1997;350:461–468
  9. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease (German Angioplasty Bypass Surgery Investigation (GABI)). N Engl J Med. 1994;331:1037–1043
  10. Ferguson TB, Hammill BG, Peterson ED, et al. A decade of change—Risk profiles and outcomes for isolated coronary artery bypass grafting procedures: A report from the STS National Database Committee and the Duke Clinical, 1990-99 Research Institute (Society of Thoracic Surgeons). Ann Thorac Surg. 2002;73:480–489discussion 489-490
  11. Ngaage DL, Griffin S, Guvendik L, et al. Changing operative characteristics of patients undergoing operations for coronary artery disease: Impact on early outcomes. Ann Thorac Surg. 2008;86:1424–1430
  12. Cohn L. In: Cardiac Surgery in the adult. Vol. 3:New York, NY: McGraw-Hill; 2008;
  13. Lytle BW, Loop FD, Taylor PC, et al. Vein graft disease: The clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1992;103:831–840
  14. Lytle BW, Loop FD, Taylor PC, et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1993;105:605–612discussion, 612-614
  15. Lytle BW, McElroy D, McCarthy P, et al. Influence of arterial coronary bypass grafts on the mortality in coronary reoperations. J Thorac Cardiovasc Surg. 1994;107:675–682discussion, 682-683
  16. Perrault L, Carrier M, Cartier R, et al. Morbidity and mortality of reoperation for coronary artery bypass grafting: Significance of atheromatous vein grafts. Can J Cardiol. 1991;7:427–430
  17. Jones EL, Lattouf OM, Weintraub WS. Catastrophic consequences of internal mammary artery hypoperfusion. J Thorac Cardiovasc Surg. 1989;98:902–907
  18. Jain U, Sullivan HJ, Pifarre R, et al. Graft atheroembolism as the probable cause of failure to wean from cardiopulmonary bypass. J Cardiothorac Anesth. 1990;4:476–480
  19. Navia D, Cosgrove DM, Lytle BW, et al. Is the internal thoracic artery the conduit of choice to replace a stenotic vein graft?. Ann Thorac Surg. 1994;57:40–43discussion, 43-44
  20. Kamdar AR, Meadows TA, Roselli EE, et al. Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg. 2008;85:1239–1245
  21. Von Kiedrowski H, Wiemer M, Franzke K, et al. Non-invasive coronary angiography: The clinical value of multi-slice computed tomography in the assessment of patients with prior coronary bypass surgery (Evaluating grafts and native vessels). Int J Cardiovasc Imaging. 2009;25:161–170
  22. Yamamoto M, Kimura F, Niinami H, et al. Noninvasive assessment of off-pump coronary artery bypass surgery by 16-channel multidetector-row computed tomography. Ann Thorac Surg. 2006;81:820–827
  23. Byrne JG, Aklog L, Adams DH, et al. Reoperative CABG using left thoracotomy: A tailored strategy. Ann Thorac Surg. 2001;71:196–200
  24. Menasche P, Kural S, Fauchet M, et al. Retrograde coronary sinus perfusion: A safe alternative for ensuring cardioplegic delivery in aortic valve surgery. Ann Thorac Surg. 1982;34:647–658
  25. Gundry SR, Razzouk AJ, Vigesaa RE, et al. Optimal delivery of Cardioplegic solution for “redo” operations. J Thorac Cardiovasc Surg. 1992;103:896–901
  26. Rosenberger P, Shernan SK, Loffler M, et al. The influence of epiaortic ultrasonography on intraoperative surgical management in 6051 cardiac surgical patients. Ann Thorac Surg. 2008;85:548–553
  27. Yau TM, Borger MA, Weisel RD, et al. The changing pattern of reoperative coronary surgery: Trends in 1230 consecutive reoperations. J Thorac Cardiovasc Surg. 2000;120:156–163
  28. Lytle BW, Loop FD, Cosgrove DM, et al. Fifteen hundred coronary reoperations (Results and determinants of early and late survival). J Thorac Cardiovasc Surg. 1987;93:847–859
  29. Loop FD, Lytle BW, Cosgrove DM, et al. Reoperation for coronary atherosclerosis (Changing practice in 2509 consecutive patients). Ann Surg. 1990;212:378–385discussion, 385-386
  30. Greaves SC, Rutherford JD, Aranki SF, et al. Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J. 1996;132:572–578
  31. Grinda JM, Zegdi R, Couetil JP, et al. Coronary reoperations: Indications, techniques and operative results (Retrospective study of 240 coronary reoperations). J Cardiovasc Surg (Torino). 2000;41:703–708
  32. He GW, Acuff TE, Ryan WH, et al. Determinants of operative mortality in reoperative coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1995;110:971–978
  33. Weintraub WS, Jones EL, Craver JM, et al. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation. 1995;92(suppl):II50–II57
  34. Keon WJ, Hendry P, Boyd WD, et al. Long-term follow-up of coronary endarterectomy. Adv Cardiol. 1988;36:19–26
  35. Livesay JJ, Cooley DA, Duncan JM, et al. Early and late results of coronary endarterectomy in 3,369 patients. Adv Cardiol. 1988;36:27–33
  36. Brenowitz JB, Kayser KL, Johnson WD. Results of coronary artery endarterectomy and reconstruction. J Thorac Cardiovasc Surg. 1988;95:1–10
  37. Goldstein J, Cooper E, Saltups A, et al. Angiographic assessment of graft patency after coronary endarterectomy. J Thorac Cardiovasc Surg. 1991;102:539–544discussion, 544-545
  38. Beretta L, Lemma M, Vanelli P, et al. Coronary “open” endarterectomy and reconstruction: Short- and long-term results of the revascularization with saphenous vein versus IMA-graft. Eur J Cardiothorac Surg. 1992;6:382–386discussion, 387
  39. Gill IS, Beanlands DS, Boyd WD, et al. Left anterior descending endarterectomy and internal thoracic artery bypass for diffuse coronary disease. Ann Thorac Surg. 1998;65:659–662
  40. Sundt TM, Camillo CJ, Mendeloff EN, et al. Reappraisal of coronary endarterectomy for the treatment of diffuse coronary artery disease. Ann Thorac Surg. 1999;68:1272–1277
  41. Byrne JG, Karavas AN, Gudbjartson T, et al. Left anterior descending coronary endarterectomy: Early and late results in 196 consecutive patients. Ann Thorac Surg. 2004;78:867–873discussion, 873-874
  42. Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol. 2009;53:232–241
  43. Rauch ED, Leach C, Barnes T, et al. Intraoperative assessment and quantification of coronary artery graft patency performed on or off cardiopulmonary bypass. J Extra Corpor Technol. 2007;39:75–80
  44. Sirivella S, Gielchinsky I, Parsonnet V. Results of coronary artery endarterectomy and coronary artery bypass grafting for diffuse coronary artery disease. Ann Thorac Surg. 2005;80:1738–1744
  45. Tabata M, Shekar PS, Couper GS, et al. Early and late outcomes of multiple coronary endarterectomy. J Cardiovasc Surg. 2008;23:697–700
  46. Asimakopoulos G, Taylor KM, Ratnatunga CP. Outcome of coronary endarterectomy: A case-control study. Ann Thorac Surg. 1999;67:989–993
  47. Djalilian AR, Shumway SJ. Adjunctive coronary endarterectomy: Improved safety in modern cardiac surgery. Ann Thorac Surg. 1995;60:1749–1754
  48. Shapira OM, Akopian G, Hussain A, et al. Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy. Ann Thorac Surg. 1999;68:2273–2278
  49. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021–1028
  50. Horvath KA, Aranki SF, Cohn LH, et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser. Circulation. 2001;104(suppl 1):I81–I84
  51. Aranki SF, Nathan M, Cohn LH. Has laser revascularization found its place yet?. Curr Opin Cardiol. 1999;14:510–514
  52. Hattler BG, Griffith BP, Zenati MA, et al. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg. 1999;68:1203–1209
  53. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–1036
  54. Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial (ATLANTIC Investigators). Angina treatments-lasers and normal therapies in comparison (Lancet). 1999;354:885–890
  55. Jones JW, Schmidt SE, Richman BW, et al. Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann Thorac Surg. 1999;67:1596–1601discussion, 1601-1602
  56. Horvath KA. Results of prospective randomized controlled trials of transmyocardial laser revascularization. Heart Surg Forum. 2002;5:33–39discussion, 39-40
  57. Aaberge L, Rootwelt K, Blomhoff S, et al. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: A late clinical follow-up of the Norwegian randomized trial with transmyocardial revascularization. J Am Coll Cardiol. 2002;39:1588–1593
  58. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial. Lancet. 1999;353:519–524
  59. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: A multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540–549
  60. Frazier OH, Tuzun E, Eichstadt H, et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: A randomized, multicenter study with 4-year follow-up. Tex Heart Inst J. 2004;31:231–239
  61. Wehberg KE, Julian JS, Todd JC, et al. Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization. Heart Surg Forum. 2003;6:328–330
  62. Allen KB, Dowling RD, Schuch DR, et al. Adjunctive transmyocardial revascularization: Five-year follow-up of a prospective, randomized trial. Ann Thorac Surg. 2004;78:458–465discussion, 458-465
  63. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306–1309
  64. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145–153
  65. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183–2189
  66. Schumacher B, Pecher P, Von Specht BU, et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation. 1998;97:645–650
  67. Simons M, Annex BH, Laham RJ, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation. 2002;105:788–793
  68. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation. 1999;100:1865–1871
  69. Hendel RC, Henry TD, Rocha-Singh K, et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect. Circulation. 2000;101:118–121
  70. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107:1359–1365
  71. Laham RJ, Rezaee M, Post M, et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther. 2000;292:795–802
  72. Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg. 1998;115:168–176discussion, 176-177
  73. Grines CL, Watkins MW, Helmer G, et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002;105:1291–1297
  74. Grines CL, Watkins MW, Mahmarian JJ, et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003;42:1339–1347
  75. Grines C, Rubanyi GM, Kleiman NS, et al. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): A new option for the treatment of coronary artery disease. Am J Cardiol. 2003;92:24N–31N
  76. Hedman M, Hartikainen J, Syvanne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 2003;107:2677–2683

PII: S1043-0679(09)00089-6

doi: 10.1053/j.semtcvs.2009.08.006

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 3 , Pages 199-206 , Autumn 2009

Article Tools

* Image Usage & Resolution